BACKGROUND: Chronic arsenic exposure currently affects >100 million persons worldwide. Methylation of ingested inorganic arsenic (InAs) to monomethylarsonic (MMAs) and dimethylarsinic (DMAs) acids relies on folate-dependent one-carbon metabolism and facilitates urinary arsenic elimination. OBJECTIVE: We hypothesized that folic acid supplementation to arsenic-exposed Bangladeshi adults would increase arsenic methylation and thereby lower total blood arsenic. DESIGN: In this randomized, double-blind, placebo-controlled trial, we evaluated blood concentrations of total arsenic, InAs, MMAs, and DMAs in 130 participants with low plasma folate (<9 nmol/L) before and after 12 wk of supplementation withfolic acid (400 microg/d) orplacebo. RESULTS:MMAs in blood was reduced by a mean +/- SE of 22.24 +/- 2.86% in the folic acid supplementation group and by 1.24 +/- 3.59% in the placebe group (P < 0.0001). There was no change in DMAs in blood; DMAs is rapidly excreted in urine as evidenced by an increase in urinary DMAs (P = 0.0099). Total blood arsenic was reduced by 13.62% in the folic acid supplementation group and by 2.49% in the placebo group (P = 0.0199). CONCLUSIONS:Folic acid supplementation to participants with low plasma concentrations of folate lowered blood arsenic concentrations, primarily by decreasing blood MMAs and increasing urinary DMAs. Therapeutic strategies to facilitate arsenic methylation, particularly in populations with folate deficiency or hyperhomocysteinemia or both, may lower blood arsenic concentrations and thereby contribute to the prevention of arsenic-induced illnesses.
RCT Entities:
BACKGROUND: Chronic arsenic exposure currently affects >100 million persons worldwide. Methylation of ingested inorganicarsenic (InAs) to monomethylarsonic (MMAs) and dimethylarsinic (DMAs) acids relies on folate-dependent one-carbon metabolism and facilitates urinary arsenic elimination. OBJECTIVE: We hypothesized that folic acid supplementation to arsenic-exposed Bangladeshi adults would increase arsenic methylation and thereby lower total blood arsenic. DESIGN: In this randomized, double-blind, placebo-controlled trial, we evaluated blood concentrations of total arsenic, InAs, MMAs, and DMAs in 130 participants with low plasma folate (<9 nmol/L) before and after 12 wk of supplementation with folic acid (400 microg/d) or placebo. RESULTS:MMAs in blood was reduced by a mean +/- SE of 22.24 +/- 2.86% in the folic acid supplementation group and by 1.24 +/- 3.59% in the placebe group (P < 0.0001). There was no change in DMAs in blood; DMAs is rapidly excreted in urine as evidenced by an increase in urinary DMAs (P = 0.0099). Total blood arsenic was reduced by 13.62% in the folic acid supplementation group and by 2.49% in the placebo group (P = 0.0199). CONCLUSIONS:Folic acid supplementation to participants with low plasma concentrations of folate lowered blood arsenic concentrations, primarily by decreasing blood MMAs and increasing urinary DMAs. Therapeutic strategies to facilitate arsenic methylation, particularly in populations with folatedeficiency or hyperhomocysteinemia or both, may lower blood arsenic concentrations and thereby contribute to the prevention of arsenic-induced illnesses.
Authors: M F Ahmed; S Ahuja; M Alauddin; S J Hug; J R Lloyd; A Pfaff; T Pichler; C Saltikov; M Stute; A van Geen Journal: Science Date: 2006-12-15 Impact factor: 47.728
Authors: M Styblo; L M Del Razo; L Vega; D R Germolec; E L LeCluyse; G A Hamilton; W Reed; C Wang; W R Cullen; D J Thomas Journal: Arch Toxicol Date: 2000-08 Impact factor: 5.153
Authors: Yu Chen; Alexander van Geen; Joseph H Graziano; Alexander Pfaff; Malgosia Madajewicz; Faruque Parvez; A Z M Iftekhar Hussain; Vesna Slavkovich; Tariqul Islam; Habibul Ahsan Journal: Environ Health Perspect Date: 2007-02-05 Impact factor: 9.031
Authors: Paul B Tchounwou; Clement G Yedjou; Udensi K Udensi; Maricica Pacurari; Jacqueline J Stevens; Anita K Patlolla; Felicite Noubissi; Sanjay Kumar Journal: Environ Toxicol Date: 2018-12-04 Impact factor: 4.119
Authors: Margaret R Karagas; Tracy Punshon; Matt Davis; Catherine M Bulka; Francis Slaughter; Despina Karalis; Maria Argos; Habibul Ahsan Journal: Curr Environ Health Rep Date: 2019-12
Authors: Megan N Hall; Caitlin G Howe; Xinhua Liu; Marie A Caudill; Olga Malysheva; Vesna Ilievski; Angela M Lomax-Luu; Faruque Parvez; Abu B Siddique; Hasan Shahriar; Mohammad N Uddin; Tariqul Islam; Joseph H Graziano; Mary V Gamble Journal: J Nutr Date: 2016-04-06 Impact factor: 4.798
Authors: Jia Zhong; Mary Speck; Bruce Urch; Frances Silverman; Diane R Gold; Petros Koutrakis; Andrea A Baccarelli Journal: Proc Natl Acad Sci U S A Date: 2017-05-08 Impact factor: 11.205
Authors: Kristin E Porter; Anamika Basu; Alan E Hubbard; Michael N Bates; David Kalman; Omar Rey; Allan Smith; Martyn T Smith; Craig Steinmaus; Christine F Skibola Journal: Environ Res Date: 2010-06-01 Impact factor: 6.498
Authors: Lizbeth López-Carrillo; Brenda Gamboa-Loira; Wendy Becerra; César Hernández-Alcaraz; Raúl Ulises Hernández-Ramírez; A Jay Gandolfi; Francisco Franco-Marina; Mariano E Cebrián Journal: Environ Res Date: 2016-08-23 Impact factor: 6.498
Authors: J Richard Pilsner; Xinhua Liu; Habibul Ahsan; Vesna Ilievski; Vesna Slavkovich; Diane Levy; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble Journal: Environ Health Perspect Date: 2008-09-26 Impact factor: 9.031
Authors: Megan N Hall; Xinhua Liu; Vesna Slavkovich; Vesna Ilievski; J Richard Pilsner; Shafiul Alam; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble Journal: Environ Health Perspect Date: 2009-01-15 Impact factor: 9.031
Authors: Megan N Hall; Xinhua Liu; Vesna Slavkovich; Vesna Ilievski; Zhongyuan Mi; Shafiul Alam; Pam Factor-Litvak; Habibul Ahsan; Joseph H Graziano; Mary V Gamble Journal: Environ Health Perspect Date: 2009-07-31 Impact factor: 9.031